Sesen Bio, Inc. License Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement between New York University and Carisma Therapeutics Inc. for Lentiviral Vector Technology
License Agreements
Sesen Bio, Inc.
Biotechnology
2022
License Agreement between The Trustees of the University of Pennsylvania and CARMA Therapeutics Inc. (November 10, 2017)
License Agreements
Sesen Bio, Inc.
Biotechnology
PA
2022
Collaboration and License Agreement between Carisma Therapeutics Inc. and ModernaTX, Inc. (January 7, 2022)
License Agreements
Sesen Bio, Inc.
Biotechnology
DE
2022
Exclusive License Agreement between University of Zürich and Viventia Bio Inc. for Anti-EGP-2 Antibody Patent Rights
License Agreements
Sesen Bio, Inc.
Biotechnology
2022
Exclusive License Agreement between Sesen Bio, Inc., Viventia Bio, Inc., and Qilu Pharmaceutical Co., Ltd. (July 30, 2020)
License Agreements
Sesen Bio, Inc.
Biotechnology
DE
2020
Amended and Restated License Agreement between Protoden Technologies Inc. and Viventia Bio Inc.
License Agreements
Sesen Bio, Inc.
Biotechnology
DE
2016
Amended and Restated Exclusive License Agreement between Merck KGaA and Viventia Bio, Inc.
License Agreements
Sesen Bio, Inc.
Biotechnology
NY
2016
Exclusive License Agreement between University of Zürich and Viventia BioInc. for Anti-EGP-2 Antibody Patent Rights
License Agreements
Sesen Bio, Inc.
Biotechnology
2016
Confidential License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Eleven Biotherapeutics, Inc. (June 10, 2016)
License Agreements
Sesen Bio, Inc.
Biotechnology
DE
2016
License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Eleven Biotherapeutics, Inc. (June 10, 2016)
License Agreements
Sesen Bio, Inc.
Biotechnology
DE
2016
First Amendment to License Agreement between Eleven Biotherapeutics, Inc. and The Schepens Eye Research Institute, Inc.
License Agreements
Sesen Bio, Inc.
Biotechnology
2016
Collaboration and License Agreement between Eleven Biotherapeutics, Inc. and ThromboGenics N.V.
License Agreements
Sesen Bio, Inc.
Biotechnology
MA
2013
License Agreement between Eleven BioTherapeutics, Inc. and The Schepens Eye Research Institute, Inc. (July 13, 2010)
License Agreements
Sesen Bio, Inc.
Biotechnology
MA
2013